Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1962 Aug;19(1):161–167. doi: 10.1111/j.1476-5381.1962.tb01437.x

Effect of α-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo

K F Gey, A Pletscher
PMCID: PMC1482243  PMID: 13898151

Abstract

In rats, three α-alkylated tryptamine derivatives (α-methyl, α-ethyl, and αα-dimethyltryptamine) caused alterations of 5-hydroxytryptamine metabolism typical of monoamine-oxidase inhibitors with short duration of action, viz., an increase of endogenous 5-hydroxytryptamine in brain, enhancement of the increase of 5-hydroxytryptamine in brain and heart after 5-hydroxytryptophan administration, an inhibition of the decrease in 5-hydroxytryptamine in brain induced by a benzoquinolizine derivative and of the increase induced by iproniazid. The increase after iproniazid was antagonized to the same extent by all the tryptamine derivatives and by harmaline, whereas dexamphetamine showed less effect. In the other experiments with brain, the tryptamine derivatives were less potent than harmaline, but somewhat more active than dexamphetamine. α-Methyltryptamine and α-ethyltryptamine were relatively more effective in the heart than in the brain. Among the tryptamine derivatives αα-dimethyltryptamine had the weakest activity in brain and in heart.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOGDANSKI D. F., PLETSCHER A., BRODIE B. B., UNDENFRIEND S. Identification and assay of serotonin in brain. J Pharmacol Exp Ther. 1956 May;117(1):82–88. [PubMed] [Google Scholar]
  2. GREIG M. E., GIBBONS A. J. The effect of D, L-alpha-ethyltryptamine acetate on serotonin metabolism. Arch Int Pharmacodyn Ther. 1962 Mar 1;136:147–152. [PubMed] [Google Scholar]
  3. GREIG M. E., SEAY P. H., FREYBURGER W. A. The pharmacology of etryptamine. J Neuropsychiatr. 1961 Feb;2(Suppl 1):131–135. [PubMed] [Google Scholar]
  4. GREIG M. E., WALK R. A., GIBBONS A. J. The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo. J Pharmacol Exp Ther. 1959 Oct;127:110–115. [PubMed] [Google Scholar]
  5. PLETSCHER A., BESENDORF H. Antagonism between harmaline and longacting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brain. Experientia. 1959 Jan 15;15(1):25–26. doi: 10.1007/BF02157082. [DOI] [PubMed] [Google Scholar]
  6. VANE J. R., COLLIER H. O., CORNE S. J., MARLEY E., BRADLEY P. B. Tryptamine receptors in the central nervous system. Nature. 1961 Sep 9;191:1068–1069. doi: 10.1038/1911068a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES